Linked Life Data

7683712

Source:http://linkedlifedata.com/resource/pubmed/id/7683712

Statements in which the resource exists as a subject.
PredicateObject
rdf:type
lifeskim:mentions
pubmed:issue
5
pubmed:dateCreated
1993-6-4
pubmed:abstractText
Despite substantial advances in the treatment of aggressive non-Hodgkin's lymphoma, therapeutic results with conventional regimens remain poor in some subsets of patients. In an attempt to improve the prognosis of such patients we used an 8-week, multidrug chemotherapy regimen of high dose-intensity.
pubmed:language
eng
pubmed:journal
pubmed:citationSubset
IM
pubmed:chemical
pubmed:status
MEDLINE
pubmed:month
May
pubmed:issn
0732-183X
pubmed:author
pubmed:issnType
Print
pubmed:volume
11
pubmed:owner
NLM
pubmed:authorsComplete
Y
pubmed:pagination
943-9
pubmed:dateRevised
2006-4-24
pubmed:meshHeading
pubmed-meshheading:7683712-Adolescent, pubmed-meshheading:7683712-Adult, pubmed-meshheading:7683712-Aged, pubmed-meshheading:7683712-Antineoplastic Combined Chemotherapy Protocols, pubmed-meshheading:7683712-Bleomycin, pubmed-meshheading:7683712-Cyclophosphamide, pubmed-meshheading:7683712-Dose-Response Relationship, Drug, pubmed-meshheading:7683712-Drug Administration Schedule, pubmed-meshheading:7683712-Etoposide, pubmed-meshheading:7683712-Female, pubmed-meshheading:7683712-Humans, pubmed-meshheading:7683712-Leucovorin, pubmed-meshheading:7683712-Lymphoma, Non-Hodgkin, pubmed-meshheading:7683712-Male, pubmed-meshheading:7683712-Methotrexate, pubmed-meshheading:7683712-Middle Aged, pubmed-meshheading:7683712-Multivariate Analysis, pubmed-meshheading:7683712-Prednisone, pubmed-meshheading:7683712-Prognosis, pubmed-meshheading:7683712-Vincristine
pubmed:year
1993
pubmed:articleTitle
Effective therapy for poor-prognosis non-Hodgkin's lymphoma with 8 weeks of high-dose-intensity combination chemotherapy.
pubmed:affiliation
Division of Oncology, Vanderbilt University, Nashville, TN.
pubmed:publicationType
Journal Article, Clinical Trial